FXYD5 and hepatocellular carcinoma: We confirmed these findings in another HCC cell line, SNU-368, in which dysadherin knockdown similarly impaired CSC properties (Supplementary Fig. 2f, g) and suppressed the YAP signaling pathway by preventing its nuclear accumulation and promoting its inhibitory phosphorylation (Supplementary Fig. 2h, i).